Some Claims are Dismissed In J&J Suit Over Guidant Deal

A federal judge allowed a breach-of-contract claim by Johnson & Johnson to proceed but dismissed others in a $5.5 billion lawsuit over Boston Scientific Corp.’s acquisition of heart-device maker Guidant last year.
The Wall Street Journal